Australië - Engels - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - cobicistat, quantity: 150 mg - tablet - excipient ingredients: croscarmellose sodium; magnesium stearate; microcrystalline cellulose; titanium dioxide; sunset yellow fcf aluminium lake; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - tybost is indicated as a pharmacokinetic enhancer of appropriate hiv-1 protease inhibitors in adults (see dosage and administration).

Canada - Engels - Health Canada

pfizer canada ulc - nelfinavir (nelfinavir mesylate) - tablet - 250mg - nelfinavir (nelfinavir mesylate) 250mg - hiv protease inhibitors

Canada - Engels - Health Canada

pfizer canada ulc - nelfinavir (nelfinavir mesylate) - powder - 50mg - nelfinavir (nelfinavir mesylate) 50mg - hiv protease inhibitors

Canada - Engels - Health Canada

glaxosmithkline inc - amprenavir - liquid - 15mg - amprenavir 15mg - hiv protease inhibitors

Australië - Engels - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - maraviroc, quantity: 150 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; calcium hydrogen phosphate; microcrystalline cellulose; magnesium stearate; colour - celsentri, in combination with other antiretroviral medicinal products, is indicated for adult patients infected with only ccr5-tropic hiv-1. the use of other active agents with celsentri is associated with a greater likelihood of treatment response.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - efavirenz, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; croscarmellose sodium; carnauba wax; lactose monohydrate; magnesium stearate; sodium lauryl sulfate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 400 - stocrin is indicated for use in combination with other antiviral agents for the treatment of hiv-1 infection in adults and children (see clinical trials; use in children).

Australië - Engels - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - tenofovir disoproxil fumarate, quantity: 300 mg; emtricitabine, quantity: 200 mg; elvitegravir, quantity: 150 mg; cobicistat, quantity: 150 mg - tablet, film coated - excipient ingredients: hyprolose; lactose monohydrate; microcrystalline cellulose; silicon dioxide; croscarmellose sodium; magnesium stearate; sodium lauryl sulfate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - stribild is indicated as a single tablet regimen for the treatment of hiv infection in treatment-na?ve adults. stribild is also indicated in certain virologically suppressed (hiv1 rna <50 copies/ml) adult patients on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see clinical trials). patients must not have a history of treatment failure or known mutations associated with resistance to the antiretroviral components of stribild (tenofovir df, emtricitabine or elvitegravir). stribild is a fixed dose combination of one integrase inhibitor, one pharmacokinetic enhancer and two nucleos(t)ide hiv-1 reverse transcriptase inhibitors.

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - rifampicin - oral capsule - 150mg

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - rifampicin - oral capsule - 150mg

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - rifampicin - oral capsule - 150mg